SC 13G 1 0001.txt INITIAL FILING ON SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 The Medicines Company, Inc. -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $0.001 per share -------------------------------------------------------------------------------- (Title of Class of Securities) 58468810 ---------- (CUSIP Number) December 31, 2000 ----------------- (Date of Events Which Require Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [x] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 9 Pages ------------------- ----------------- CUSIP No. 58468810 13G Page 2 of 9 Pages ------------------- ----------------- ---------- --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Warburg, Pincus Ventures, L.P. ---------- --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] ---------- --------------------------------------------------------------------- 3 SEC USE ONLY ---------- --------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware -------------------- ------ ---------------------------------------------------- 5 SOLE VOTING POWER -0- ------ ---------------------------------------------------- NUMBER OF 6 SHARED VOTING POWER SHARES BENEFICIALLY 9,605,256 OWNED BY EACH ------ ---------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH -0- ------ ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 9,605,256 ---------- --------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,605,256 ---------- --------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] ---------- --------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 28.01% ---------- --------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN ---------- --------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! ------------------- ----------------- CUSIP No. 58468810 13G Page 3 of 9 Pages ------------------- ----------------- ---------- --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Warburg, Pincus & Co. ---------- --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] ---------- --------------------------------------------------------------------- 3 SEC USE ONLY ---------- --------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York -------------------- ------ ---------------------------------------------------- 5 SOLE VOTING POWER -0- ------ ---------------------------------------------------- NUMBER OF 6 SHARED VOTING POWER SHARES BENEFICIALLY 9,605,256 OWNED BY EACH ------ ---------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH -0- ------ ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 9,605,256 ---------- --------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,605,256 ---------- --------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] ---------- --------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 28.01% ---------- --------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN ---------- --------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! ------------------- ----------------- CUSIP No. 58468810 13G Page 4 of 9 Pages ------------------- ----------------- ---------- --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON E.M. Warburg, Pincus & Co., LLC ---------- --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] ---------- --------------------------------------------------------------------- 3 SEC USE ONLY ---------- --------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York -------------------- ------ ---------------------------------------------------- 5 SOLE VOTING POWER -0- ------ ---------------------------------------------------- NUMBER OF 6 SHARED VOTING POWER SHARES BENEFICIALLY 9,605,256 OWNED BY EACH ------ ---------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH -0- ------ ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 9,605,256 ---------- --------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,605,256 ---------- --------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] ---------- --------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 28.01% ---------- --------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* OO ---------- --------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Item 1(a). Name of Issuer: --------- --------------- The Medicines Company, Inc. (the "Issuer") Item 1(b). Address of Issuer's Principal Executive Offices: --------- ------------------------------------------------ One Cambridge Center Cambridge, MA 02142 Items 2(a) Name of Person Filing; Address of Principal ---------- ------------------------------------------- and (b). Business Office: ------- ---------------- This statement is filed by and on behalf of (a) Warburg, Pincus Ventures, L.P., a Delaware limited partnership ("WPV"); (b) Warburg, Pincus & Co., a New York general partnership ("WP"); and (c) E.M. Warburg, Pincus & Co., LLC, a New York limited liability company ("EMW LLC"), which manages WPV. Lionel I. Pincus is the managing partner of WP and the managing member of EMW LLC and may be deemed to control both WP and EMW LLC. The members of EMW LLC are substantially the same as the partners of WP. The business address of each of the foregoing is 466 Lexington Avenue, New York, New York 10017. WPV and EMW LLC have shared ownership and voting dispositive power with respect to 9,605,256 shares of Common Stock (as defined below). WP has shared ownership and voting dispositive power with respect to 9,605,256 shares of Common Stock. Item 2(c). Citizenship: --------- ------------ Not Applicable Item 2(d). Title of Class of Securities: --------- ----------------------------- Common Stock, par value $0.001 per share (the "Common Stock") Item 2(e). CUSIP Number: --------- ------------- 58468810 Item 3. If this statement is filed pursuant to ss.ss. 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person is filing as a: (a)[ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b)[ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). 5 of 9 pages (c)[ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d)[ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e)[ ] An investment adviser in accordance with ss. 240.13d-1(b)(1)(ii)(E). (f)[ ] An employee benefit plan or endowment fund in accordance with ss. 240.13d-1(b)(1)(ii)(F). (g)[ ] A parent holding company or control person in accordance with ss. 240.13d-1(b)(1)(ii)(G). (h)[ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i)[ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). (j)[ ] Group, in accordance with ss. 240.13d-1(b)(1)(ii)(J). If this statement is filed pursuant to ss. 240.13d-1(c), check this box [ ]. Not Applicable Item 4. Ownership: ------ ---------- Warburg, Pincus Ventures, L.P. ------------------------------ (a) Amount beneficially owned: 9,605,256 shares of Common Stock, as of December 31, 2000. (b) Percent of Class: 28.01% (c) (i) Sole power to vote or direct the vote: -0- (ii) Shared power to vote or direct the vote: 9,605,256 (iii)Sole power to dispose of or direct the disposition of: -0- (iv)Shared power to dispose of or direct the disposition of: 9,605,256 Warburg, Pincus & Co. --------------------- (a) Amount beneficially owned: 9,605,256 shares of Common Stock, as of December 31, 2000. (b) Percent of Class: 28.01% 6 of 9 pages (c) (i) Sole power to vote or direct the vote: -0- (ii) Shared power to vote or direct the vote: 9,605,256 (iii) Sole power to dispose of or direct the disposition of: -0- (iv) Shared power to dispose of or direct the disposition of: 9,605,256 E.M. Warburg, Pincus & Co., LLC ------------------------------- (a) Amount beneficially owned: 9,605,256 shares of Common Stock, as of December 31, 2000. (b) Percent of Class: 28.01% (c) (i) Sole power to vote or direct the vote: -0- (ii) Shared power to vote or direct the vote: 9,605,256 (iii) Sole power to dispose of or direct the disposition of: -0- (iv) Shared power to dispose of or direct the disposition of: 9,605,256 Item 5. Ownership of Five Percent or Less of a Class: ------ --------------------------------------------- Not Applicable Item 6. Ownership of More than Five Percent on Behalf ------- --------------------------------------------- of Another Person: ------------------ Not Applicable Item 7. Identification and Classification of the ------ ---------------------------------------- Subsidiary Which Acquired the Security Being -------------------------------------------- Reported on By the Parent Holding Company: ------------------------------------------ Not Applicable Item 8. Identification and Classification of ------ ------------------------------------ Members of the Group: --------------------- Not Applicable 7 of 9 pages Item 9. Notice of Dissolution of Group: ------ ------------------------------- Not Applicable Item 10. Certification: ------- -------------- Not Applicable 8 of 9 pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 14, 2001 WARBURG, PINCUS VENTURES, L.P. By: Warburg, Pincus & Co., General Partner By: /s/ Scott A. Arenare ------------------------------ Scott A. Arenare, Attorney-in-fact WARBURG, PINCUS & CO. By: /s/ Scott A. Arenare ------------------------------ Scott A. Arenare, Attorney-in-fact E.M. WARBURG, PINCUS & CO., LLC By: /s/ Scott A. Arenare ------------------------------ Scott A. Arenare, Vice President 9 of 9 pages